Click on the calendar to find a variety of upcoming events.
Check back soon for updates!
Welcome, Dr. Sharpless!
Norman E. “Ned” Sharpless, M.D., took the oath of office to become the 15th director of the NCI on Tuesday, Oct. 17, 2017. Dr. Sharpless comes to NCI from the University of North Carolina School of Medicine, Chapel Hill, where he served as director of the NCI-Designated Lineberger Comprehensive Cancer Center and as the Wellcome Distinguished Professor in Cancer Research. Read the https://www.cancer.gov/news-events/press-releases/2017/sharpless-nci-directorhttps://www.cancer.gov/news-events/press-releases/2017/sharpless-nci-director.
Investing in the Future of Cancer Research
NCI recently released its Annual Plan & Budget Proposal for FY 2019 that highlights areas for which additional support will enable more progress. Visit https://plan.cancer.gov to learn more.
We hope that the following information will assist you as you are recovering from these storms. If you are a grantee, applicant, or a cancer patient, health care provider, or grantee and have been affected by these storms, please visit Emergency Resources for the Cancer Community.
CRCHD recently reissued the following Career Development Awards to Promote Diversity funding opportunity announcements (FOAs). These awards provide funding and three to five years of protected time to support underrepresented individuals in intensive, mentored and non-mentored, cancer-related biomedical, behavioral, or clinical research career development experiences. To learn more about these awards, please visit CRCHD's Continuing Umbrella of Research Experiences (CURE) page.
A notice was recently issued to inform the research community of the termination of PAR-16-399 Mentored Patient-Oriented Research Career Development Award to Promote Diversity (K23). This termination is effective immediately. See Notice Number: NOT-CA-17-033.
The NCI Mentored Clinical Scientist Research Career Development Award to Promote Diversity (K08) will now support training in Basic, Translational, and Patient-Oriented Research (POR), as well as combinations of Basic, Translational and POR. Additionally, the salary support and research development support information have been revised for new applications. Changes are effective as of June 12, 2017. See Notice Number: NOT-CA-17-035.
For the latest updates, follow CRCHD on social media!
GMaP is a regional strategy to build critical “hubs” for the support and efficient management of cancer and cancer health disparities research, diversity training, and education/outreach programs.The National Cancer Institute's (NCI) Center to Reduce Cancer Health Disparities (CRCHD) manages GMaP.
Is to enhance capacity in the areas of disparities research; recruitment and career/professional development of underrepresented investigators, trainees, and students; communication and dissemination; and evaluation for the support and efficient management of cancer health disparities (CHD) research, training, and outreach.
To learn more, visit the CRCHD GMaP webpage: www.cancer.gov/about-nci/organization/crchd/inp/gmap